Clemens Warnke - Dissemin

Papers authored by Clemens Warnke

This paper is made freely available by the publisher.

2020 Martijn T. Wijburg, Clemens Warnke

, Joep Killestein, Mike P. Wattjes

Application of “Mentzer’s PML case definition” to natalizumab-treated patients in the setting of strict MRI-based pharmacovigilance

Download from link.springer.com

This paper was not found in any repository, but could be made available legally by the author.

Sargis Abrahamyan, Bettina Eberspächer, Muna-Miriam Hoshi, Lilian Aly, Felix Luessi, Sergiu Groppa, Luisa Klotz, Sven G. Meuth, Christoph Schroeder, Thomas Grüter

, Björn Tackenberg, Friedemann Paul, Florian Then-Bergh, Tania Kümpfel, Frank Weber and 14 other authors

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

Upload

Erik Ellwardt, Leoni Rolfes, Julia Klein, Katrin Pape, Tobias Ruck, Heinz Wiendl, Michael Schroeter, Frauke Zipp, Sven G. Meuth, Clemens Warnke

, Stefan Bittner

Ocrelizumab initiation in patients with MS

Download from doi.org

F. Schweitzer, S. Laurent, G. R. Fink, Michael H. Barnett, H. P. Hartung

, C. Warnke

Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis

Download from link.springer.com

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

A. Ladwig, J. Suh, F. Schweitzer, P. Roeth, G. Remke, C. Warnke

, M. Schroeter, E. Izquierdo-Alvarez, E. Bonmann, G. R. Fink, C. Pallasch, H. Lehmann

Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis

Upload

F. Schweitzer, A. Ladwig, S. Laurent, M. Schroeter, S. Goelz, U. Wieland, S. Silling, C. Warnke

Is the gut a relevant reservoir for persistent jcpyv infection?

Upload

2019 Sebastian Proschinger, Niklas Joisten, Annette Rademacher, Marit L. Schlagheck, David Walzik, Alan J. Metcalfe, Max Oberste, Clemens Warnke

, Wilhelm Bloch, Alexander Schenk, Jens Bansi, Philipp Zimmer

Influence of combined functional resistance and endurance exercise over 12 weeks on matrix metalloproteinase-2 serum concentration in persons with relapsing-remitting multiple sclerosis – a community-based randomized controlled trial

Download from doi.org

Sophia von Martial, Tobias J. Brix

, Luisa Klotz, Philipp Neuhaus, Klaus Berger, Clemens Warnke

, Sven G. Meuth, Heinz Wiendl, Martin Dugas

EMR-integrated minimal core dataset for routine health care and multiple research settings: A case study for neuroinflammatory demyelinating diseases

Download from doi.org

Clemens Warnke

, Hans-Peter Hartung

Big data in MS—What can we learn from large international observational studies such as MSBase?

Upload

Stefan Bittner, Sinah Engel, Christoph Lange, Martin S. Weber, Aiden Haghikia, Felix Luessi, Thomas Korn, Luisa Klotz, Antonios Bayas, Friedemann Paul, Christoph Heesen, Martin Stangel, Brigitte Wildemann, Florian Then Bergh, Björn Tackenberg and 13 other authors

Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose

Download from link.springer.com

Paulus S. Rommer, Ron Milo, May H. Han, Sammita Satyanarayan, Johann Sellner, Larissa Hauer, Zsolt Illes, Clemens Warnke

, Sarah Laurent, Martin S. Weber, Yinan Zhang, Olaf Stuve

Immunological Aspects of Approved MS Therapeutics

Download from doi.org

Distributing this paper is prohibited by the publisher

Frauke Zipp, Christiane Gasperi

, Anke Salmen, Tania Kuempfel, Gisela Antony, Ralf A. Linker, Antonios Bayas, Christoph Heesen, Uwe K. Zettl, Friedemann Paul, Tania Kümpfel, Martin Stangel, Orhan Aktas, Florian Then Bergh, Ilya Ayzenberg and 47 other authors

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis

Upload

Finja Schweitzer, Sarah Laurent, Gereon R. Fink, Michael H. Barnett, Stephen Reddel, Hans-Peter Hartung, Clemens Warnke

Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis:

Upload

Clemens Warnke

, Hans-Peter Hartung

Challenging a concept: Pulsed treatment regimen—No risk of PML?

Upload

Kira Blankenbach, Nicholas Schwab

, Benjamin Hofner, Ortwin Adams, Brigitte Keller-Stanislawski, Clemens Warnke

Natalizumab-associated progressive multifocal leukoencephalopathy in Germany

Upload

Sharmili Edwin Thanarajah, Harald Prüss, Clemens Warnke

, Michael T. Barbe, Michael Schroeter, Gereon R. Fink, Oezguer A. Onur

Atypical Autoimmune Encephalitis With Neuropil Antibodies Against a Yet Unknown Epitope

Download from doi.org

Moritz Förster, Patrick Küry, Orhan Aktas, Clemens Warnke

, Joachim Havla, Reinhard Hohlfeld, Jan Mares, Hans-Peter Hartung

, David Kremer

Managing Risks with Immune Therapies in Multiple Sclerosis

Upload

I. Meinl, O. Adams, C. Warnke

, R. Hohlfeld, T. Kuempfel

Very early detection of progressive multifocal leukoencephalopathy: should we perform cerebrospinal fluid analysis before switching from natalizumab to ocrelizumab?

Upload

Poul Erik H. Jensen, Clemens Warnke

, Kathleen Ingenhoven, Luca Piccoli

, Marcia Gasis, Christina Hermanrud, Blanca M. Fernandez-Rodriguez, Malin Ryner, Daniel Kramer, Jenny Link

, Ryan Ramanujam, Michael Auer, Dorothea Buck, Verena Grummel, Elisa Bertotti and 28 other authors

Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

Upload

Jonas Graf, Verena Leussink, Thomas Dehmel, Marius Ringelstein, Norbert Goebels, Ortwin Admas, Colin MacKenzie, Clemens Warnke

, Torsten Feldt, Anna Lammerskitten, Luisa Klotz, Sven Meuth, Heinz Wiendl, Hans-Peter Hartung, Orhan Aktas and 1 other authors

Infectious Risk Stratification in Multiple Sclerosis Patients Receiving Immunotherapy - An Update

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Clemens Warnke